UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 11, 2006
ENDOCARE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or Other Jurisdiction of
Incorporation)
|
|
0-27212
(Commission
File Number)
|
|
33-0618093
(I.R.S. Employer
Identification Number) |
201 Technology Drive
Irvine, California 92618
(Address of Principal Executive Offices, including zip code)
(949) 450-5400
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 1.01 Entry into a Material Definitive Agreement.
On January 13, 2006, Endocare, Inc. (the Company) entered into a Stock Purchase Agreement (the
Stock Purchase Agreement) to sell all of the stock of its wholly owned subsidiary, Timm Medical
Technologies, Inc. (Timm) to Plethora Solutions Holdings plc (Plethora), a company listed on
the London Stock Exchange. The transaction is expected to close by mid-February 2006. The Stock
Purchase Agreement provides that the Company will receive proceeds of $9,500,000, payable as
follows:
|
|
|
$8,075,000 in cash; and |
|
|
|
|
$1,425,000 by means of a secured convertible promissory note (the Note) due and
payable in full, together with all accrued interest, on the date 24 months or, under
certain circumstances, 15 months following the closing date of the transaction,
bearing interest at 5% per annum. |
The Note may be converted into Plethora ordinary shares at the option of the Company at any time.
Plethora may force the conversion of the shares under certain circumstances after the date 12
months following the closing date of the transaction.
The Company agreed to retain certain assets and liabilities of Timm, including past due state and
local tax liabilities and obligations and rights to payment (a) from a previous disposition of
assets by Timm, and (b) related to certain litigation to which Timm is a party.
The Stock Purchase Agreement contains customary representations, warranties, covenants and
conditions to closing.
The foregoing description of the Stock Purchase Agreement is qualified in its entirety by the full
text of such document, which is filed as Exhibit 2.1 to this report and is incorporated herein by
reference.
Item 2.05 Costs Associated with Exit or Disposal Activities.
On January 11, 2006, a Special Committee of our Board of Directors approved the sale of Timm
pursuant to the Stock Purchase Agreement, as described above. The information contained above in
Item 1.01 is hereby incorporated by reference into this Item 2.05.
We estimate that the total costs associated with the sale of Timm pursuant to the Stock Purchase
Agreement will be $592,000. These costs include the following components:
|
|
|
a fee of $542,000 payable to our investment bank, Seven Hills Partners LLC; and |
|
|
|
|
a success fee in the amount of $50,000 payable to an employee of Timm. |
We expect that all of these costs will result in future cash expenditures.
In addition, pursuant to the terms of the Stock Purchase Agreement, we have agreed, subject to
certain limitations, to indemnify Plethora against certain losses that Plethora may incur after the
closing of the sale of Timm. Any costs related to these indemnification obligations, including any
future cash expenditures, cannot be estimated at this time and will be recognized in future periods
when and if incurred.